|
|
|
|
|
|
|
|
Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Full Text View - ClinicalTrials.gov
This study is not yet open for participant recruitment.
Verified May 2012 by Mayo Clinic
First Received on May 23, 2012.
Last Updated on May 24, 2012
History of Changes
Sponsor: | Mayo Clinic |
---|---|
Information provided by (Responsible Party): | Keith Knutson, Ph.D., Mayo Clinic |
ClinicalTrials.gov Identifier: | NCT01606241 |
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.